Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Merck
AstraZeneca
Cipla
Citi
Fuji
Argus Health
Farmers Insurance

Generated: November 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019781

« Back to Dashboard

NDA 019781 describes PROMETRIUM, which is a drug marketed by Virtus Pharms and is included in one NDA. It is available from three suppliers. Additional details are available on the PROMETRIUM profile page.

The generic ingredient in PROMETRIUM is progesterone. There are fifty-seven drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the progesterone profile page.
Summary for 019781
Tradename:PROMETRIUM
Applicant:Virtus Pharms
Ingredient:progesterone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019781
Ingredient-typeProgesterone
Medical Subject Heading (MeSH) Categories for 019781
Suppliers and Packaging for NDA: 019781
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROMETRIUM progesterone CAPSULE;ORAL 019781 NDA A-S Medication Solutions 50090-3240 50090-3240-0 10 CAPSULE in 1 BOTTLE (50090-3240-0)
PROMETRIUM progesterone CAPSULE;ORAL 019781 NDA Bryant Ranch Prepack 63629-6809 63629-6809-1 30 CAPSULE in 1 BOTTLE (63629-6809-1)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength100MG
Approval Date:May 14, 1998TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Oct 15, 1999TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength300MG
Approval Date:Oct 15, 1999TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cantor Fitzgerald
Queensland Health
Dow
Baxter
Boehringer Ingelheim
Healthtrust
McKinsey
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.